Expression and role of interleukin‑1β and associated biomarkers in deep vein thrombosis

Pai,Rouzimaimaiti Zila; Fang,Qingbo; Tian,Guanglei; Zhu,Bing; Ge,Xiaohu

doi:10.3892/etm.2021.10800

Expression and role of interleukin‑1β and associated biomarkers in deep vein thrombosis

Authors:
- Rouzimaimaiti Zila Pai
- Qingbo Fang
- Guanglei Tian
- Bing Zhu
- Xiaohu Ge
View Affiliations

Affiliations: Department of General Practice, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang Uygur Autonomous Region 830001, P.R. China, Department of Vascular Surgery, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang Uygur Autonomous Region 830001, P.R. China, Department of Hepatobiliary Surgery, Graduate School, Xinjiang Medical University, Urumqi, Xinjiang Uygur Autonomous Region 830001, P.R. China
Published online on: September 27, 2021 https://doi.org/10.3892/etm.2021.10800
Article Number: 1366
Copyright: © Pai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lower extremity deep vein thrombosis (DVT) is a common peripheral vascular disease, in which inflammation plays an important role. The aim of the present study was to investigate the expression and role of inflammatory factors in DVT. A rat model of venous thrombosis of the lower extremities was established through venous ligation surgery. The rats were examined at 2, 8, 24, 48 and 72 h after the induction of inferior venous stenosis and compared with control and sham surgery groups. The serum levels of interleukin‑1β (IL‑1β), tissue factor (TF) and xanthine oxidase (XOD) were measured using ELISAs. The morphology of the DVT tissue was observed by hematoxylin and eosin staining. Circulating endothelial cells (CECs) in peripheral blood were counted by flow cytometry. Reverse transcription‑quantitative PCR and western blotting were used to detect mRNA and protein expression, respectively. The serum levels of IL‑1β, TF and XOD exhibited no significant differences between the control and sham surgery groups. However, those in the rat model of DVT presented an upward trend from 2 to 24 h and peaked at 24 h, with a significant difference from the respective levels in the control and sham surgery groups. The histopathological analysis revealed the presence of red and mixed thrombi in the rats 2‑48 h following the induction of inferior venous stenosis group with inflammatory cell infiltration in the vascular wall. Thrombus formation was evident after 72 h. While significant difference was observed in the number of CECs in the peripheral blood between the control and sham surgery groups, the number of peripheral blood CECs in the rats with inferior venous stenosis group increased from 8 to 72 h, with significant differences among these groups. The mRNA levels of IL‑1β, TF, XOD and NF‑κB in the tissues peaked at 24 h, with significant differences compared with those in the control and sham surgery groups. In addition, the protein expression level of NF‑κB increased from 2 to 72 h. In conclusion, these results suggest that the high expression of IL‑1β, TF, XOD and NF‑κB may promote thrombus formation.

View Figures

View References

1	Crop MJ, Siemes C, Berendes P, van der Straaten F, Willemsen S and Levin MD: Influence of C-reactive protein levels and age on the value of D-dimer in diagnosing pulmonary embolism. Eur J Haematol. 92:147–155. 2014.PubMed/NCBI View Article : Google Scholar
2	Ibrahim NA, Hassan FM, Elgari MM and Abdalla SE: Risk factors for deep vein thrombosis of lower extremities in sudanese women. Vasc Health Risk Manag. 14:157–164. 2018.PubMed/NCBI View Article : Google Scholar
3	Li Y, Wei WF, Lin SM, Liu ZJ, Huang HC and Qiu WL: Expression of inflammatory factors in pregnant women with acute venous thrombosis and its relationship with the degree of vascular injury. Guangdong Med J. 35:558–560. 2014.(In Chinese).
4	Alexander P and Giangola G: Deep venous thrombosis and pulmonary embolism: Diagnosis, prophylaxis, and treatment. Ann Vasc Surg. 13:318–327. 1999.PubMed/NCBI View Article : Google Scholar
5	Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, et al: Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 149:698–707. 2008.PubMed/NCBI View Article : Google Scholar
6	Kahn SR: The post thrombotic syndrome. Thromb Res. 127 (Suppl 3):S89–S92. 2011.PubMed/NCBI View Article : Google Scholar
7	Zhang T, Li Q, Wang L and Li G: Expression variations and clinical significance of MMP-1, MMP-2 and inflammatory factors in serum of patients with deep venous thrombosis of lower extremity. Exp Ther Med. 17:181–186. 2019.PubMed/NCBI View Article : Google Scholar
8	Zhou J, Pang L, Zuo B and Yan B: Discussion on the clinical application of deep vein thrombosis risk assessment module. Attend Pract and Res. 11:117–118. 2015.(In Chinese).
9	Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, et al: Guidelines on the diagnosis and management of acute pulmonary embolism: The task force for the diagnosis and management of acute pulmonary embolism of the European society of cardiology (ESC). Eur Heart J. 29:2276–2315. 2008.PubMed/NCBI View Article : Google Scholar
10	Goekoop RJ, Steeghs N, Niessen RW, Jonkers GJ, Dik H, Castel A, Gelder LW, Vlasveld LT, van Klink RC, Planken EV and Huisman MV: Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and wells' simplified decision rule. Thromb Haemostasis. 97:146–150. 2007.PubMed/NCBI
11	Deem TL and Cook-Mills JM: Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: Role of reactive oxygen species. Blood. 104:2385–2393. 2004.PubMed/NCBI View Article : Google Scholar
12	Erusalimsky JD: Vascular endothelial senescence: From mechanisms to pathophysiology. J Appl Physiol (1985). 106:326–332. 2009.PubMed/NCBI View Article : Google Scholar
13	Fan LM, Douglas G, Bendall JK, McNeill E, Crabtree MJ, Hale AB, Mai A, Li JM, McAteer MA, Schneider JE, et al: Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation. 129:2661–2672. 2014.PubMed/NCBI View Article : Google Scholar
14	Wakefield TW, Myers DD and Henke PK: Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 28:387–391. 2008.PubMed/NCBI View Article : Google Scholar
15	Kanaji N, Sato T, Nelson A, Wang X, Li Y, Kim M, Nakanishi M, Basma H, Michalski J, Farid M, et al: Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signaling. J Inflam Res. 4:127–138. 2011.PubMed/NCBI View Article : Google Scholar
16	Phan SH, Gannon DE, Varani J, Ryan US and Ward PA: Xanthine oxidase activity in rat pulmonary artery endothelial cells and its alteration by activated neutrophils. Am J Pathol. 134:1201–1211. 1989.PubMed/NCBI
17	Ma J, Li X, Wang Y, Yang Z and Luo J: Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus. Int J Mol Med. 40:1869–1880. 2017.PubMed/NCBI View Article : Google Scholar
18	Humphries J, Gossage JA, Modarai B, Burnand KG, Sisson TH, Murdoch C and Smith A: Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis. J Vasc Surg. 50:1127–1134. 2009.PubMed/NCBI View Article : Google Scholar
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
20	Feng YM, Chen XH and Zhang X: Roles of PECAM-1 in cell function and disease progression. Eur Rev Med Pharmacol Sci. 20:4082–4088. 2016.PubMed/NCBI
21	Woodfin A, Voisin MB and Nourshargh S: PECAM-1: A multi-functional molecule in inflammation and vascular biology. Arterioscler Thromb Vasc Biol. 27:2514–2523. 2007.PubMed/NCBI View Article : Google Scholar
22	Tuzcu ZB, Asicioglu E, Sunbul M, Ozben B, Arikan H and Koc M: Circulating endothelial cell number and markers of endothelial dysfunction in previously preeclamptic women. Am J Obstet Gynecol. 213(533)2015.PubMed/NCBI View Article : Google Scholar
23	van de Veerdonk FL and Netea MG: New insights in the immunobiology of IL-1 family members. Front Immunol. 4(167)2013.PubMed/NCBI View Article : Google Scholar
24	Moriwaki Y, Yamamoto T and Higashino K: Distribution and pathophysiologic role of molybdenum-containing enzymes. Histol Histopathol. 12:513–524. 1997.PubMed/NCBI
25	Zeki S, Miura S, Suzuki H, Watanabe N, Adachi M, Yokoyama H, Horie Y, Saito H, Kato S and Ishii H: Xanthine oxidase-derived oxygen radicals play significant roles in the development of chronic pancreatitis in WBN/Kob rats. J Gastroenterol Hepatol. 17:606–616. 2002.PubMed/NCBI View Article : Google Scholar
26	Lassegue B, Martin AS and Griendling KK: Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 110:1364–1390. 2012.PubMed/NCBI View Article : Google Scholar
27	Nomura J, Busso N, Ives A, Matsui C, Tsujimoto S, Shirakura T, Tamura M, Kobayashi T, So A and Yamanaka Y: Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep. 4(4554)2014.PubMed/NCBI View Article : Google Scholar
28	Breitenstein A, Tanner FC and Luscher TF: Tissue factor and cardiovascular disease: Quo vadis? Circ J. 74:3–12. 2010.PubMed/NCBI View Article : Google Scholar
29	Yao XJ, Zhao ZM and Xia T: Inflammation and Thrombosis. Chinese J Thromb Hemostasis. 21:190–192. 2015.(In Chinese).
30	Lopez-Vilchez I, Galan AM, Hernandez MR, Caballo C, Roque M, Diaz-Ricart M, White JG and Escolar G: Platelet-associated tissue factor enhances platelet reactivity and thrombin generation in experimental studies in vitro. Thromb Res. 130:e294–e300. 2012.PubMed/NCBI View Article : Google Scholar
31	Li J and Yan W: Relationship between neutrophil activation and pathological progression of venous thrombosis. Chinese J Trad Med Traumatology Orthopedics. 17:70–72. 2009.(In Chinese).
32	Lawrence T: The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 1(a001651)2009.PubMed/NCBI View Article : Google Scholar
33	Beg AA and Baldimore D: An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science. 274:782–784. 1996.PubMed/NCBI View Article : Google Scholar
34	Blix K, Jensvoll H, Brækkan SK and Hansen JB: White blood cell count measured prior to cancer development is associated with future risk of venous thromboembolism-the tromsø study. PLoS One. 8(e73447)2013.PubMed/NCBI View Article : Google Scholar
35	Boyle S, White RH, Brunson A and Wun T: Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia. Blood. 121:4782–4790. 2013.PubMed/NCBI View Article : Google Scholar
36	Malgor RD and Labropoulos N: Re-modelling of venous thrombosis. Phlebology. 28 (Suppl 1):S25–S28. 2013.PubMed/NCBI View Article : Google Scholar
37	Deatrick KB, Obi A, Luke CE, Elfline MA, Sood V, Upchurch GR Jr, Jaffer F, Wakefield TW and Henke PK: Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT. Thromb Res. 132:360–366. 2013.PubMed/NCBI View Article : Google Scholar
38	Ripplinger CM, Kessinger CW, Li C, Kim JW, McCarthy JR, Weissleder R, Henke PK, Lin CP and Jaffer FA: Inflammation modulates murine venous thrombosis resolution in vivo: Assessment by multimodal fluorescence molecular imaging. Arterioscler Thromb Vasc Biol. 32:2616–2624. 2012.PubMed/NCBI View Article : Google Scholar
39	Rodriguez AL, Wojcik BM, Wrobleski SK, Myers DD Jr, Wakefield TW and Diaz JA: Statins, inflammation and deep vein thrombosis: A systematic review. J Thromb Thrombolysis. 33:371–382. 2012.PubMed/NCBI View Article : Google Scholar